Jun 29, 2022
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.21 to $0.02.
The split itself did not change the total investment value.
Regulus Therapeutics Inc. (RGLS) trades on the NASDAQ Capital Market in the Biotechnology industry.
Regulus Therapeutics Inc. company overviewThe latest split shown was on June 29, 2022. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records 2 reverse splits between October 4, 2018 and June 29, 2022.